Document ID: chunk:federal_register_of_legislation:F2023L01747:schedule:1:p11
Version: federal_register_of_legislation:F2023L01747
Segment Type: schedule
Provision Reference: sch 1 (pt 11/31)
Character Range: 34620–38565

column headed "Responsible Person": PF substitute: FK

     [46]               Schedule 1, Part 1, entry for Flucloxacillin in the form Capsule 250 mg (as sodium monohydrate)
     omit:
         a  APO-Flucloxacillin  TX  MP NP MW  C5414     24  0  24
                                    PDP       C5298     24  0  24

     [47]               Schedule 1, Part 1, entry for Flucloxacillin in the form Capsule 500 mg (as sodium monohydrate)
         (a)           omit:
         a  APO-Flucloxacillin  TX  MP     C5414 C6169  P5414  24  0  24
                                    NP MW  C5414               24  0  24
                                    PDP    C5298               24  0  24

         (b)           omit:
         a  APO-Flucloxacillin  TX  MP  C5414 C6169  P6169  48  1  24

     [48]               Schedule 1, Part 1, entry for Furosemide in the form Tablet 20 mg
         (a)           omit:
         a  Urex-M  RW  MP NP        100  1  50

         (b)           omit:
         a  Urex-M  RW  MP NP     P14238  200  1  50

     [49]               Schedule 1, Part 1, entry for Furosemide in the form Tablet 40 mg
         (a)           omit:
            Urex  RW  MP NP        100  1  100

         (b)           omit:
            Urex  RW  MP NP     P14238  200  1  100

     [50]               Schedule 1, Part 1, entry for Gabapentin in each of the forms: Capsule 100 mg; Capsule 300 mg; and Capsule 400 mg
     omit:
         a  Gabapentin APOTEX  TY  MP NP  C4928     100  5  100

     [51]               Schedule 1, Part 1, entry for Glimepiride in the form Tablet 3 mg
     omit:
         a  Amaryl  SW  MP NP        30  5  30

     [52]               Schedule 1, Part 1, omit entry for Hydralazine

     [53]               Schedule 1, Part 1, entry for Hydromorphone in the form Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL
     substitute:
   Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL  Oral     Hikma  LM  PDP    C10859                                             473  0  473
                                                                                               MP NP  C10764 C10770 C10777 C11697  P10764 P10770 P10777  473  0  473
                                                                                               MP NP  C10764 C10770 C10777 C11697  P11697                473  1  473

     [54]               Schedule 1, Part 1, after entry for Hydromorphone in the form Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL
     insert:
   Oral solution containing hydromorphone hydrochloride 1mg per mL, 1mL (S19A)  Oral     Hydromorphone hydrochloride oral solution, USP (Medsurge)  DZ  MP NP  C10764 C10770 C10777 C11697  P10764 P10770 P10777  473  0  473
                                                                                                                                                        PDP    C10859                                             473  0  473
                                                                                                                                                        MP NP  C10764 C10770 C10777 C11697  P11697                473  1  473

     [55]               Schedule 1, Part 1, entry for Ibrutinib in the form Capsule 140 mg [Maximum Quantity: 90; Number of Repeats: 5]
         (a)           omit from the column headed "Circumstances": C14344
         (b)           insert in numerical order in the column headed "Circumstances": C14788
         (c)           omit from the column headed "Purposes": P14344 substitute: P14788

     [56]               Schedule 1, Part 1, entry for Ibrutinib in the form Capsule 140 mg [Maximum Quantity: 120; Number of Repeats: 5]
         (a)           omit from the column headed "Circumstances": C14344
         (b)           insert in numerical order in the column headed "Circumstances": C14788

     [57]